Importer of Controlled Substances Registration: Research Triangle Institute, 4593 [2015-01578]
Download as PDF
<![CDATA[
4593
Federal Register / Vol. 80, No. 18 / Wednesday, January 28, 2015 / Notices
Controlled substance
Schedule
4-Anilino-N-phenethyl-4-piperidine
(8333).
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
II
II
II
II
II
The company plans to import the
listed controlled substances for internal
use, and to manufacture bulk
intermediates for sale to its customers.
Dated: January 21, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of noroxymorphone (9668), a
basic class of narcotic controlled
substance listed in schedule II.
The company plans to import small
quantities of the listed controlled
substance for the National Institute on
Drug Abuse for research activities.
Dated: January 21, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015–01578 Filed 1–27–15; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2015–01587 Filed 1–27–15; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
[Docket No. DEA–392]
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Rhodes
Technologies
Importer of Controlled Substances
Registration: Research Triangle
Institute
ACTION:
ACTION:
Notice of registration.
Research Triangle Institute
applied to be registered as an importer
of a certain basic class of narcotic
controlled substance. The DEA grants
Research Triangle Institute registration
as an importer of this controlled
substance.
By notice
dated April 21, 2014, and published in
the Federal Register on April 28, 2014,
79 FR 23373, Research Triangle
Institute, Kenneth S. Rehder, Ph.D.,
Hermann Building, East Institute Drive,
P.O. Box 12194, Research Triangle Park,
North Carolina 27709, applied to be
registered as an importer of a certain
basic class of narcotic controlled
substance. No comments or objections
were submitted for this notice.
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of Research Triangle
Institute to import the basic class of
controlled substance is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
mstockstill on DSK4VPTVN1PROD with NOTICES
VerDate Sep<11>2014
16:41 Jan 27, 2015
Jkt 235001
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before March 30, 2015.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on March
DATES:
SUMMARY:
SUPPLEMENTARY INFORMATION:
Notice of application.
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
13, 2014, Rhodes Technologies, 498
Washington Street, Coventry, Rhode
Island 02816, applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Controlled substance
Tetrahydrocannabinols (7370) .....
Methylphenidate (1724) ................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Levorphanol (9220) ......................
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Tapentadol (9780) ........................
Fentanyl (9801) ............................
Schedule
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for conversion and sale to dosage form
manufacturers.
In reference to drug code 7370 the
company plans to bulk manufacture a
synthetic tetrahydrocannabinol. No
other activity for this drug code is
authorized for this registration.
Dated: January 21, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015–01598 Filed 1–27–15; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Manufacturer of Controlled
Substances Registration: Johnson
Matthey, Inc.
ACTION:
Notice of registration.
Johnson Matthey, Inc. applied
to be registered as a manufacturer of
certain basic classes of controlled
substances. The DEA grants Johnson
Matthey, Inc. registration as a
manufacturer of those controlled
substances.
SUMMARY:
By notice
dated September 25, 2014, and
published in the Federal Register on
October 7, 2014, 79 FR 60498, Johnson
Matthey, Inc., Custom Pharmaceuticals
Department, 2003 Nolte Drive, West
Deptford, New Jersey 08066–1742,
applied to be registered as a
manufacturer of a certain basic class of
controlled substance. No comments or
objections were submitted to this notice.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\28JAN1.SGM
28JAN1
]]>Agencies
[Federal Register Volume 80, Number 18 (Wednesday, January 28, 2015)]
[Notices]
[Page 4593]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01578]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration: Research Triangle
Institute
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Research Triangle Institute applied to be registered as an
importer of a certain basic class of narcotic controlled substance. The
DEA grants Research Triangle Institute registration as an importer of
this controlled substance.
SUPPLEMENTARY INFORMATION: By notice dated April 21, 2014, and
published in the Federal Register on April 28, 2014, 79 FR 23373,
Research Triangle Institute, Kenneth S. Rehder, Ph.D., Hermann
Building, East Institute Drive, P.O. Box 12194, Research Triangle Park,
North Carolina 27709, applied to be registered as an importer of a
certain basic class of narcotic controlled substance. No comments or
objections were submitted for this notice.
The Drug Enforcement Administration (DEA) has considered the
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the
registration of Research Triangle Institute to import the basic class
of controlled substance is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated the company's
maintenance of effective controls against diversion by inspecting and
testing the company's physical security systems, verifying the
company's compliance with state and local laws, and reviewing the
company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above-named company is granted
registration as an importer of noroxymorphone (9668), a basic class of
narcotic controlled substance listed in schedule II.
The company plans to import small quantities of the listed
controlled substance for the National Institute on Drug Abuse for
research activities.
Dated: January 21, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-01578 Filed 1-27-15; 8:45 am]
BILLING CODE 4410-09-P
